Skip to main content
SpringerLink
Log in

The Authors’ Reply

  • Correspondence
  • Published:
CNS Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I

References

  1. Rapoport AM, Freitag F, Pearlman SH. Innovative delivery systems for migraine: the clinical utility of a transdermal patch for the acute treatment of migraine. CNS Drugs 2010; 24: 929–40

    Article  PubMed  CAS  Google Scholar 

  2. Lipton RB, Hamelsky SW, Dayno JM. What do patients with migraine want from acute migraine treatment? Headache 2002; 42 Suppl. 1: 3–9

    Article  PubMed  Google Scholar 

  3. Goldstein J, Pugach N, Smith T, et al. Acute anti-migraine efficacy and tolerability of Zelrix, a novel iontophoretic transdermal patch of sumatriptan. Research abstract presented at the 14th International Headache Congress; 2009 Sep 10–13; Philadelphia (PA). Headache 2010; 50: 509–15

    Article  Google Scholar 

  4. Goadsby PJ, Lipton RB, Ferrari MD. Migraine: current understanding and treatment. N Engl J Med 2002; 346: 257–70

    Article  PubMed  CAS  Google Scholar 

  5. Ferrari MD, Goadsby PJ, Roon KI, et al. Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials. Cephalalgia 2002; 22: 633–58

    Article  PubMed  CAS  Google Scholar 

  6. Davies GM, Santanello NC, Lipton RB. Determinants of patient satisfaction with migraine therapy. Cephalalgia 2000; 20: 554–60

    Article  PubMed  CAS  Google Scholar 

  7. Lipton RB, Stewart WF. Acute migraine therapy: do doctors understand what patients with migraine want from therapy? Headache 1999; 39 Suppl. 2: S20–6

    Article  Google Scholar 

  8. Roon KI, Lipton RB, Goadsby PJ, et al. Efficacy of six oral triptans at 1 h post-dose: a meta-analysis [abstract no. P2-K1]. Cephalalgia 2001; 21: 405

    Article  Google Scholar 

  9. Imitrex® (sumatriptan succinate tablets): US prescribing information [online]. Available from URL: http://us.gsk.com/products/assets/us_imitrex_tablets.pdf [Accessed 2010 Dec 14]

  10. Imitrex® (sumatriptan nasal spray): US prescribing information [online]. Available from URL: http://us.gsk.com/products/assets/us_imitrex_nasal_spray.pdf [Accessed 2010 Dec 14]

  11. Silberstein SD. Migraine symptoms: results of a survey of self-reported migraineurs. Headache 1995; 35: 387–96

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, The David Geffen School of Medicine at UCLA, Los Angeles, California, USA

    Alan M. Rapoport

  2. Department of Family Medicine, Rosalind Franklin University of Medicine and Science, North Chicago, Illinois, USA

    Fred Freitag

  3. Department of Biology, Armstrong Atlantic State University, Savannah, Georgia, USA

    Starr H. Pearlman

Authors
  1. Alan M. Rapoport
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fred Freitag
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Starr H. Pearlman
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rapoport, A.M., Freitag, F. & Pearlman, S.H. The Authors’ Reply. CNS Drugs 25, 171–174 (2011). https://doi.org/10.2165/11587780-000000000-00000

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/11587780-000000000-00000

Keywords

Search

Navigation